Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 115 points (0.7%) at 16,388 as of Friday, Feb. 28, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,987 issues advancing vs. 938 declining with 158 unchanged. The Services sector currently sits up 0.5% versus the S&P 500, which is up 0.6%. Top gainers within the sector include Central European Media ( CETV), up 65.1%, Mercadolibre ( MELI), up 14.2%, Kroger ( KR), up 3.0%, LKQ Corporation ( LKQ), up 2.9% and Target ( TGT), up 2.8%. On the negative front, top decliners within the sector include American Public Education ( APEI), down 21.5%, KBR ( KBR), down 14.8%, Wendy's ( WEN), down 4.2%, Ctrip.com International ( CTRP), down 3.1% and Starbucks Corporation ( SBUX), down 2.2%. TheStreet would like to highlight 3 stocks pushing the sector higher today: 3. CVS Caremark ( CVS) is one of the companies pushing the Services sector higher today. As of noon trading, CVS Caremark is up $0.92 (1.3%) to $73.08 on light volume. Thus far, 1.9 million shares of CVS Caremark exchanged hands as compared to its average daily volume of 5.8 million shares. The stock has ranged in price between $72.14-$73.25 after having opened the day at $72.25 as compared to the previous trading day's close of $72.16. CVS Caremark Corporation, together with its subsidiaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. CVS Caremark has a market cap of $85.4 billion and is part of the retail industry. Shares are up 0.8% year-to-date as of the close of trading on Thursday. Currently there are 15 analysts who rate CVS Caremark a buy, no analysts rate it a sell, and 4 rate it a hold. TheStreet Ratings rates CVS Caremark as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, increase in net income and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full CVS Caremark Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.